Diality Inc.: Ravi Parthasarathy Joins as Chief Technology Officer, Empowering Dialysis Patients

Diality Inc., a California-based medical device company, has announced the appointment of Ravi Parthasarathy as its new Chief Technology Officer. Parthasarathy brings with him extensive experience in product development team leadership, having most recently worked at ICU Medical as the Vice President of Device Engineering. Prior to that, he held leadership positions at Baxter Healthcare, Motorola, Siemens Medical Systems, and General Motors.

Osman Khawar, M.D., CEO of Diality expressed his excitement about Parthasarathy joining the team. He stated that Parthasarathy’s expertise and alignment with Diality’s mission, vision, and values make him a perfect fit for the company. As Diality continues to grow, Clayton Poppe will transition into the role of Chief Scientific Officer (CSO), overseeing research, quality and regulatory functions.

Diality is committed to delivering innovative solutions to improve the quality of life for dialysis patients. The Moda-flxTM Hemodialysis System currently in development is a patient-centric solution aimed at empowering healthcare professionals to make choices that benefit patients and their clinical practice. Parthasarathy expressed his enthusiasm about joining Diality citing the company’s mission of improving lives affected by kidney disease as a significant motivation.

For more information about Diality and its products visit www.diality.com or find them on LinkedIn